Learn about new initiatives underway to overcome ovarian cancer and meet people who are committed to making a difference.
Stories found here are from Seeds of Hope, the monthly e‑newsletter.
Two major organizations in the charitable sector, the Canadian Cancer Society and the Canadian Breast Cancer Foundation, recently announced their official merger.
When she was diagnosed with ovarian cancer, Sue Deacon left no stone unturned as she searched for more information and the latest clinical trials. Her mother had passed away from the same disease and Sue wondered if her own diagnosis was the result of a hereditary predisposition.
Having received an initial diagnosis of ovarian cancer in 2006, Donna Pepin is currently facing recurrence. But she refuses to let her diagnosis get in the way of her making a difference as an advocate for the cause.
Studies show that when surgery for ovarian cancer is performed by a gynecologic oncologist, outcomes are significantly improved. This is among many reasons Ovarian Cancer Canada has a longstanding partnership with the Society of Gynecologic Oncology of Canada (GOC), an organization that convenes gynecologic oncologists and other healthcare professionals involved in gynecological cancer care and management.
After being diagnosed and treated for ovarian cancer, many women worry the disease will return. In fact, studies show that more than 70% of cancer survivors experience fear of recurrence.
On learning she was pregnant with her second child, Erin was elated. As time went on she started to feel sick. But nothing outside of the normal course of a pregnancy, she thought. Nonetheless, at the urging of her family and friends, Erin went to her doctor. Following test after test, a six pound mass was detected on her left ovary.
An ongoing shortfall in research funding has stalled scientific progress on ovarian cancer. Though the disease continues to claim hundreds of Canadian lives each year, government has provided little in the way of support.
Fearing what might happen if their genetic information is shared with insurance companies and employers, Canadians are not pursuing tests that could save their lives. There have been reports of premiums skyrocketing and work contracts ending due to knowledge of genetic mutations that may carry increased risks for certain diseases.
Months after a team of volunteer advocates and staff members took to Parliament Hill to discuss the issues surrounding ovarian cancer; Bill S-201: An Act to prohibit and prevent genetic discrimination had its second reading in the House of Commons.
This information was provided by Barbara Fleming, a woman living with ovarian cancer. It is a personal account of things that helped her through chemotherapy.